0	1	[	[	(
1	15	Glucocorticoid	glucocorticoid	NN
16	25	receptors	receptor	NNS
26	28	on	on	IN
29	34	human	human	JJ
35	45	peripheral	peripheral	JJ
46	57	mononuclear	mononuclear	JJ
58	61	and	and	CC
62	79	polymorphonuclear	polymorphonuclear	JJ
80	90	leucocytes	leucocyte	NNS
90	91	:	:	:
92	99	changes	change	NNS
100	102	in	in	IN
103	111	patients	patient	NNS
112	116	with	with	IN
117	132	yang-deficiency	yang-deficiency	NN
132	133	]	]	)
135	137	It	it	PRP
138	141	was	be	VBD
142	147	found	find	VBN
148	152	that	that	IN
152	153	,	,	,
154	156	in	in	IN
157	163	former	former	JJ
164	169	works	work	NNS
169	170	,	,	,
171	174	the	the	DT
175	189	glucocorticoid	glucocorticoid	NN
190	199	receptors	receptor	NNS
200	201	(	(	(
201	204	GCR	GCR	NNP
204	205	)	)	)
206	208	on	on	IN
209	219	peripheral	peripheral	JJ
220	225	mixed	mixed	JJ
226	236	leucocytes	leucocyte	NNS
237	239	in	in	IN
240	248	patients	patient	NNS
249	253	with	with	IN
254	269	Yang-deficiency	Yang-deficiency	NNP
270	274	were	be	VBD
275	284	decreased	decrease	VBN
284	285	.	.	.

286	288	In	in	IN
289	293	this	this	DT
294	298	work	work	NN
298	299	,	,	,
300	303	the	the	DT
304	309	mixed	mixed	JJ
310	320	leucocytes	leucocyte	NNS
321	325	were	be	VBD
326	333	further	further	RB
334	343	separated	separate	VBN
344	348	into	into	IN
349	360	mononuclear	mononuclear	JJ
361	362	(	(	(
362	365	MNL	MNL	NNP
365	366	)	)	)
367	370	and	and	CC
371	388	polymorphonuclear	polymorphonuclear	JJ
389	390	(	(	(
390	393	PML	PML	NNP
393	394	)	)	)
395	405	leucocytes	leucocyte	NNS
405	406	,	,	,
407	410	and	and	CC
411	414	GCR	GCR	NNP
415	419	were	be	VBD
420	430	determined	determine	VBN
431	433	in	in	IN
434	438	each	each	DT
439	443	part	part	NN
444	446	of	of	IN
447	457	leucocytes	leucocyte	NNS
457	458	.	.	.

459	462	GCR	GCR	NNP
463	465	on	on	IN
466	469	MNL	MNL	NNP
470	473	and	and	CC
474	477	PML	PML	NNP
478	480	in	in	IN
481	482	6	6	CD
483	487	Yang	Yang	NNP
488	497	deficient	deficient	JJ
498	506	patients	patient	NNS
507	511	were	be	VBD
512	516	3473	3473	CD
517	520	+/-	+/-	SYM
521	524	413	413	CD
525	528	and	and	CC
529	533	4433	4433	CD
534	537	+/-	+/-	CC
538	541	651	651	CD
542	552	sites/cell	sites/cell	NNS
553	565	respectively	respectively	RB
565	566	,	,	,
567	580	statistically	statistically	RB
581	592	significant	significant	JJ
593	597	from	from	IN
598	601	the	the	DT
602	608	normal	normal	JJ
609	616	control	control	NN
617	622	group	group	NN
623	624	(	(	(
624	628	4462	4462	CD
629	632	+/-	+/-	CC
633	636	962	962	CD
637	640	and	and	CC
641	645	5622	5622	CD
646	649	+/-	+/-	CC
650	653	782	782	CD
654	664	sites/cell	sites/cell	NNS
665	677	respectively	respectively	RB
677	678	,	,	,
679	680	P	p	NN
681	685	less	less	JJR
686	690	than	than	IN
691	695	0.05	0.05	CD
695	696	)	)	)
696	697	.	.	.

698	701	GCR	GCR	NNP
702	704	on	on	IN
705	708	MNL	MNL	NNP
708	709	,	,	,
710	713	PML	PML	NNP
714	717	and	and	CC
718	723	mixed	mixed	JJ
724	734	leucocytes	leucocyte	NNS
735	737	in	in	IN
738	739	5	5	CD
740	748	patients	patient	NNS
749	753	were	be	VBD
754	764	determined	determine	VBN
765	779	simultaneously	simultaneously	RB
779	780	,	,	,
781	784	and	and	CC
785	788	all	all	DT
789	796	lowered	lower	VBD
797	801	from	from	IN
802	805	the	the	DT
806	813	control	control	NN
814	819	group	group	NN
819	820	.	.	.

821	824	The	the	DT
825	832	results	result	NNS
833	837	were	be	VBD
838	842	3369	3369	CD
843	846	+/-	+/-	SYM
847	850	370	370	CD
850	851	,	,	,
852	856	4986	4986	CD
857	860	+/-	+/-	CC
861	864	419	419	CD
865	868	and	and	CC
869	873	4524	4524	CD
874	877	+/-	+/-	CC
878	881	852	852	CD
882	892	sites/cell	sites/cell	NNS
893	905	respectively	respectively	RB
905	906	,	,	,
907	911	with	with	IN
912	915	the	the	DT
916	922	lowest	low	JJS
923	926	GCR	gcr	NN
927	929	on	on	IN
930	933	MNL	MNL	NNP
934	937	and	and	CC
938	945	highest	high	JJS
946	948	on	on	IN
949	952	PML	PML	NNP
952	953	.	.	.